Cell and Gene Therapy

Manufacturer Solutions


When healthcare advances, so must the processes to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.

Let’s build the future together. 

 



Innovative delivery systems, like cell and gene therapies, are requiring new levels of coordination and orchestration of multiple services, from scheduling and complex logistics to provider preparation and patient services, in order to ensure treatment success. We have an incredible opportunity to meet the growing challenges of our industry and be the “go-to” global partner for manufactures in need of specialty solutions from clinical through commercial life stages.

DOUG COOK, EVP AND PRESIDENT, GLOBAL COMMERCIALIZATION SERVICES AND ANIMAL HEALTH, AMERISOURCEBERGEN

Working together with manufacturers to identify and overcome barriers

Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry—insights we leverage to help reduce logistics, order-to-cash, clinical trial, commercialization, and patient support challenges for our partners and the patients they serve.
Working together to alleviate barriers
  • Expert guidance on market access, reimbursement and policy
  • Complete logistics support, from pre-clinical through clinical trials to commercialization and post-launch solutions to ensure product quality standards are maintained 
  • Established relationships with thousands of healthcare providers optimizes the order to cash process and ease of prodcut access
  • Innovative patient access, affordability and adherence solutions unique to cell and gene therapies
  • Complete data solutions provide visibility to the patient journey

“Cell and gene therapies promise to transform patient outcomes by unlocking cures for diseases, but the complexity of these therapies presents innovators with unprecedented challenges across logistics, commercialization, market access and reimbursement. We have the privilege of speaking to and working with many of the innovators in this space and believe we have best-in-class solutions to help therapy owners scale their connection of patients with treatments.”

STEVE COLLIS CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER, AMERISOURCEBERGEN

AmerisourceBergen Partnerships

Collaboration is essential to the creation of clinical and commercial scale logistics platforms. In order to support therapy developers, we have integrated systems and technology with a number of key partner organizations.

 

Vineti

Cytiva

TrakCel

Savsu Technologies

Advanced Therapies Treatment Centres

Redefining moments that matter

We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians and our key stakeholders.

Redefining moments that matter

Connect with our experts

Glenn Martin, VP, Branded & Specialty Rx Channel Strategy & Strategic Accounts

Melissa Lattanzi, Sr Director, Specialty & Branded Channel Strategy and Product Access

Request a discussion

AmerisourceBergen in the News

国产AV在线免播放观看-国产美女视频在线播放